薬剤溶出バルーン(DEB)：企業と競争環境...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 11
2 Introduction 12
2.1 Catalyst 13
3 Competitive Assessment 15
3.1 Overview 15
3.2 Product Profiles by Company 17
3.2.1 Aachen Resonance 18
3.2.2 B. Braun 20
3.2.3 Biotronik 27
3.2.4 Blue Medical 30
3.2.5 Cardionovum 36
3.2.6 C.R. Bard 41
3.2.7 Concept Medical Research 47
3.2.8 Cook Medical 51
3.2.9 Eurocor 53
3.2.10 Medrad (Bayer Healthcare) 68
3.2.11 Medtronic 70
3.2.12 Minvasys 78
4 Pipeline Products 81
4.1 Overview 81
4.2 Pipeline by Stage of Development 82
4.3 Pipeline Product Profiles 84
4.3.1 NF-κB Decoy Oligo DEB 84
4.3.2 Drug-Coated AngioSculpt 86
4.3.3 BioPath 89
4.3.4 BioStream 90
4.3.5 Boston Scientific Drug-Coated Balloon 91
4.3.6 Coroflex DEBlue 92
4.3.7 Covidien Drug-Coated Balloon 94
4.3.8 DSM Biomedical and Caliber Therapeutics DEB 96
4.3.9 Elixir Medical Corporation DCB 97
4.3.10 LifeTech Scientific Corporation DEB 97
4.3.11 Micell Technologies Drug-Coated Balloon 97
4.3.12 Drug-Coated Chocolate DEB 99
4.3.13 Passeo-18 Lux 101
4.3.14 Vascular Nanotransfer Technologies Drug-Coated Balloon 102
4.3.15 WOMBAT DCB 103
5 Current and Future Players 105
5.1 Overview 105
5.2 Trends in Corporate Strategy 106
5.3 Company Profiles 109
5.3.1 Aachen Resonance 109
5.3.2 AnGes MG 110
5.3.3 AngioScore 112
5.3.4 AVIDAL Vascular 114
5.3.5 B. Braun 116
5.3.6 Biosensors International 118
5.3.7 Biotronik 120
5.3.8 Blue Medical 122
5.3.9 Boston Scientific Corporation 124
5.3.10 Caliber Therapeutics 126
5.3.11 Cardionovum 128
5.3.12 Concept Medical Research 130
5.3.13 Cook Medical 132
5.3.14 Covidien 134
5.3.15 C.R. Bard 136
5.3.16 DSM Biomedical 138
5.3.17 Elixir Medical Corporation 140
5.3.18 Eurocor 142
5.3.19 LifeTech Scientific Corporation 144
5.3.20 Medtronic 146
5.3.21 Micell Technologies 148
5.3.22 Minvasys 149
5.3.23 TriReme Medical 151
5.3.24 Vascular Nanotransfer Technologies 153
6 Appendix 155
6.1 Bibliography 155
6.2 Abbreviations 165
6.3 Report Methodology 168
6.3.1 Overview 168
6.3.2 Coverage 168
6.3.3 Secondary Research 169
6.3.4 Forecasting Methodology 169
6.4 Physicians and Specialists Included in this Study 171
6.5 Physician Survey 174
6.6 About the Authors 175
6.6.1 Analysts 175
6.6.2 Global Head of Healthcare 176
6.7 About MediPoint 177
6.8 About GlobalData 177
6.9 Disclaimer 177